$1.22
+0.0100 (+0.83%)
At Close: Jun 15, 2026
BENSALEM, Pa., July 23, 2021 /PRNewswire/ -- Law Offices of Howard G.
3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120%
11:51am, Friday, 23'rd Jul 2021
Former penny stocks biotech analysts are bullish on right now. The post 3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120% appeared first on Penny Stocks to Buy, Picks, News and In
Ocugen Likely Can't Get a Boost From the FDA Until 2023
07:00am, Thursday, 22'nd Jul 2021
It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete.
New York, New York--(Newsfile Corp. - July 22, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Oc
New York, New York--(Newsfile Corp. - July 20, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGN) alleging tha
New York, New York--(Newsfile Corp. - July 20, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2
New York, New York--(Newsfile Corp. - July 20, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Oc
Covid Vaccine Stocks: Why NVAX, OCGN, MRNA and QDEL Are on the Move Today
12:16pm, Tuesday, 20'th Jul 2021
Stocks for companies developing or already distributing a vaccine for covid are on the move Tuesday and we've got all the details. The post Covid Vaccine Stocks: Why NVAX, OCGN, MRNA and QDEL Are on t
Why Shares of Ocugen Climbed Today
05:33pm, Monday, 19'th Jul 2021
The delta variant is lifting the tide of companies associated with COVID testing and prevention.
New York, New York--(Newsfile Corp. - July 19, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Oc
Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. and Certain Officers - OCGN
09:48pm, Friday, 16'th Jul 2021
NEW YORK, July 16, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN) and certain of its officers.
New York, New York--(Newsfile Corp. - July 16, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGEN).Sh
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:59pm, Friday, 16'th Jul 2021
MALVERN, Pa., July 16, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness dise
New York, New York--(Newsfile Corp. - July 16, 2021) - WHY: New York, N.Y., July 16, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASD
New York, New York--(Newsfile Corp. - July 16, 2021) - To: All persons or entities who purchased or otherwise acquired securities of Ocugen, Inc. ("Ocugen") (NASDAQ: OCGN) between February 2, 2021 and
Sign In
Buy OCGN